Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome

This study has been completed.
Sponsor:
Information provided by:
Sanofi
ClinicalTrials.gov Identifier:
NCT00563771
First received: November 21, 2007
Last updated: January 24, 2008
Last verified: January 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2004
  Estimated Primary Completion Date: No date given